{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:52Z","timestamp":1792809532428,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmic Physiol. Opt."],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Glaucoma is one of the leading causes of blindness worldwide, necessitating evidence-informed interventions and strategies to improve the quality of life of affected individuals. In this review, we examined progress in evidence over the past decade and discussed its implications and the ways forward for delivery of glaucoma care globally, embedded within a rapid evidence and gap-mapping exercise of systematic reviews and\/or meta-analyses published between 2015 and 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Using a predefined conceptual framework, ten domains were identified as relevant to evidence synthesis in glaucoma care. Within each domain, we assessed areas of strength and identified remaining evidence gaps. Findings were synthesised narratively and recommendations provided to inform future research priorities and advancement in glaucoma care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Across the systematic reviews published over the past decade, the majority focused on risk factors (15.6%), genetic factors (12.4%) and the effectiveness of various treatment modalities (44.4%). In the absence of a coordinated global approach, substantial duplication of effort across review groups was observed. In addition, several critical gaps remain in the evidence base, particularly regarding the cost-effectiveness of the interventions, improving equitable access to care and the availability of context-specific evidence for low- and middle-income countries. Improved rigour in the evidence from primary studies should be a key priority for future research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>A substantial gap exists in the glaucoma care evidence base that limits its utility for informing clinical guidelines and policy development. Systematic reviewers should have a comprehensive understanding of the existing evidence landscape in glaucoma care prior to conceptualising and designing review projects. Strengthening the methodological quality of both systematic reviews and the underlying primary studies is essential to support the development of robust clinical guidelines and effective global policies in glaucoma care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s44402-026-00218-w","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:40:52Z","timestamp":1792410052000},"page":"1296-1304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Progress in the Synthesis of Evidence in Glaucoma: What We Know and the Gaps that Remain"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0236-0101","authenticated-orcid":false,"given":"Mapa Prabhath","family":"Piyasena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9960-2989","authenticated-orcid":false,"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4805-9322","authenticated-orcid":false,"given":"Augusto","family":"Azuara-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"218_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ajo.2025.12.013","volume":"283","author":"Z Wang","year":"2026","unstructured":"Wang Z, Xue CC, Li Y, Wu Y, Pan Z, Li F, et al. Global glaucoma prevalence: burden and projection to 2060. Am J Ophthalmol. 2026;283:324\u201335. https:\/\/doi.org\/10.1016\/j.ajo.2025.12.013.","journal-title":"Am J Ophthalmol"},{"key":"218_CR2","doi-asserted-by":"publisher","unstructured":"Vision Loss Expert Group of the Global Burden of Disease Study & the GBD 2019 Blindness and Vision Impairment Collaborators.\u00a0 Global estimates on the number of people blind or visually impaired by glaucoma: a meta-analysis from 2000 to 2020. Eye. 2024;38:2036\u201346. https:\/\/doi.org\/10.1038\/s41433-024-02995-5.","DOI":"10.1038\/s41433-024-02995-5"},{"key":"218_CR3","unstructured":"Cochrane AL. Effectiveness and efficiency: random reflections on health services. London: Nuffield Provincial Hospitals Trust; 1972."},{"key":"218_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/icvts\/ivt451","volume":"18","author":"A Stavrou","year":"2014","unstructured":"Stavrou A, Challoumas D, Dimitrakakis G. Archibald Cochrane (1909\u20131988): the father of evidence-based medicine. Interact CardioVasc Thorac Surg. 2014;18:121\u20134. https:\/\/doi.org\/10.1093\/icvts\/ivt451.","journal-title":"Interact CardioVasc Thorac Surg"},{"key":"218_CR5","first-page":"561","volume":"58","author":"Z Abbas","year":"2008","unstructured":"Abbas Z, Raza S, Ejaz K. Systematic reviews and their role in evidence-informed health care. J Pak Med Assoc. 2008;58:561\u20137. PMID:18998310.","journal-title":"J Pak Med Assoc"},{"key":"218_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/wvn.12621","volume":"20","author":"L Connor","year":"2023","unstructured":"Connor L, Dean J, McNett M, Tydings DM, Shrout A, Gorsuch PF, et al. Evidence-based practice improves patient outcomes and healthcare system return on investment: Findings from a scoping review. Worldviews Evid Based Nurs. 2023;20:6\u201315. https:\/\/doi.org\/10.1111\/wvn.12621.","journal-title":"Worldviews Evid Based Nurs"},{"key":"218_CR7","unstructured":"Cochrane Eyes and Vision. Review summaries [Internet]. Available from: https:\/\/eyes.cochrane.org\/links-our-reviews. Accessed 15 Dec 2025."},{"key":"218_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-2-82","volume":"2","author":"MMG Leeflang","year":"2013","unstructured":"Leeflang MMG, Deeks JJ, Takwoingi Y, Macaskill P. Cochrane diagnostic test accuracy reviews. Syst Rev. 2013;2:82. https:\/\/doi.org\/10.1186\/2046-4053-2-82.","journal-title":"Syst Rev"},{"key":"218_CR9","doi-asserted-by":"publisher","first-page":"CD007394.","DOI":"10.1002\/14651858.cd007394","volume":"4","author":"MMG Leeflang","year":"2008","unstructured":"Leeflang MMG, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev. 2008;4:CD007394. https:\/\/doi.org\/10.1002\/14651858.cd007394.","journal-title":"Cochrane Database Syst Rev"},{"key":"218_CR10","doi-asserted-by":"publisher","first-page":"CD008803.","DOI":"10.1002\/14651858.CD008803.pub2","volume":"11","author":"M Michelessi","year":"2015","unstructured":"Michelessi M, Lucenteforte E, Oddone F, Brazzelli M, Parravano M, Franchi S, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015;11:CD008803. https:\/\/doi.org\/10.1002\/14651858.CD008803.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"218_CR11","doi-asserted-by":"publisher","first-page":"CD012947.","DOI":"10.1002\/14651858.CD012947.pub2","volume":"5","author":"A Jindal","year":"2020","unstructured":"Jindal A, Ctori I, Virgili G, Lucenteforte E, Lawrenson JG. Non-contact tests for identifying people at risk of primary angle closure glaucoma. Cochrane Database Syst Rev. 2020;5:CD012947. https:\/\/doi.org\/10.1002\/14651858.CD012947.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"218_CR12","doi-asserted-by":"publisher","first-page":"e073975.","DOI":"10.1136\/bmjopen-2023-073975","volume":"13","author":"A Azuara-Blanco","year":"2023","unstructured":"Azuara-Blanco A, Lawrenson JG, King AJ, Foster PJ, Virgili G, Guiney M, et al. Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study. BMJ Open. 2023;13:e073975. https:\/\/doi.org\/10.1136\/bmjopen-2023-073975.","journal-title":"BMJ Open"},{"key":"218_CR13","doi-asserted-by":"publisher","first-page":"e000533.","DOI":"10.1136\/bmjophth-2020-000533","volume":"5","author":"S Keel","year":"2020","unstructured":"Keel S, Evans JR, Block S, Bourne R, Calonge M, Cheng CY, et al. Strengthening the integration of eye care into the health system: methodology for the development of the WHO package of eye care interventions. BMJ Open Ophthalmol. 2020;5:e000533. https:\/\/doi.org\/10.1136\/bmjophth-2020-000533.","journal-title":"BMJ Open Ophthalmol"},{"key":"218_CR14","doi-asserted-by":"publisher","first-page":"e012230.","DOI":"10.1136\/bmjopen-2016-012230","volume":"6","author":"F Kyari","year":"2016","unstructured":"Kyari F, Nolan W, Gilbert C. Ophthalmologists\u2019 practice patterns and challenges in achieving optimal management for glaucoma in Nigeria: results from a nationwide survey. BMJ Open. 2016;6:e012230. https:\/\/doi.org\/10.1136\/bmjopen-2016-012230.","journal-title":"BMJ Open"},{"key":"218_CR15","doi-asserted-by":"publisher","first-page":"e046319.","DOI":"10.1136\/bmjopen-2020-046319","volume":"11","author":"JR Evans","year":"2021","unstructured":"Evans JR, Gordon I, Lawrenson JG, Parker R, Rowe FJ, Virgili G, et al. Identifying priority review questions for Cochrane Eyes and Vision: protocol for a priority setting exercise. BMJ Open. 2021;11:e046319. https:\/\/doi.org\/10.1136\/bmjopen-2020-046319.","journal-title":"BMJ Open"},{"key":"218_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/cesm.12014","volume":"1","author":"JR Evans","year":"2023","unstructured":"Evans JR, Gordon I, Azuara-Blanco A, Bowen M, Braithwaite T, Crosby-Nwaobi R, et al. Identifying important questions for Cochrane systematic review in Eyes and Vision: report of a priority setting exercise. Cochrane Evid Synth Methods. 2023;1:e12014. https:\/\/doi.org\/10.1002\/cesm.12014.","journal-title":"Cochrane Evid Synth Methods"},{"key":"218_CR17","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1017\/rsm.2025.25","volume":"16","author":"H Khalil","year":"2025","unstructured":"Khalil H, Welch V, Grainger M, Campbell F. Methodology for mapping reviews, evidence maps and gap maps. Res Synth Methods. 2025;16:786\u201396. https:\/\/doi.org\/10.1017\/rsm.2025.25.","journal-title":"Res Synth Methods"},{"key":"218_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1017\/rsm.2025.10032","volume":"17","author":"C Lunny","year":"2026","unstructured":"Lunny C, Jain N, Nazari T, Kosaner-Kleib M, Santos L, Goodman I, et al. Exploring the methodological quality and risk of bias in 200 systematic reviews: a comparative study of ROBIS and AMSTAR-2 tools. Res Synth Methods. 2026;17:63\u201392. https:\/\/doi.org\/10.1017\/rsm.2025.10032.","journal-title":"Res Synth Methods"},{"key":"218_CR19","doi-asserted-by":"publisher","unstructured":"Rainkie DC, Abedini ZS, Abdelkader NN. Reporting and methodological quality of systematic reviews and meta-analysis with protocols in diabetes mellitus type II: a systematic review. PLoS ONE. 2020;15:e0243091. https:\/\/doi.org\/10.1371\/journal.pone.0243091.","DOI":"10.1371\/journal.pone.0243091"},{"key":"218_CR20","doi-asserted-by":"publisher","DOI":"10.1192\/bjo.2025.10876","volume":"11","author":"R Strawbridge","year":"2025","unstructured":"Strawbridge R, Sharma D, Kisely S, Cristea IA, Young AH, Kaufman KR. Enhancing the quality of systematic reviews and meta-analyses. BJPsych Open. 2025;11:e266. https:\/\/doi.org\/10.1192\/bjo.2025.10876.","journal-title":"BJPsych Open"},{"key":"218_CR21","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page M et al. Cochrane handbook for systematic reviews of interventions. Wiley-Blackwell: United Kingdom; 2019.","DOI":"10.1002\/9781119536604"},{"key":"218_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jclinepi.2019.11.012","volume":"119","author":"Y Gao","year":"2020","unstructured":"Gao Y, Cai Y, Yang K, Liu M, Shi S, Chen J, et al. Methodological and reporting quality in non-Cochrane systematic review updates could be improved: a comparative study. J Clin Epidemiol. 2020;119:36\u201346. https:\/\/doi.org\/10.1016\/j.jclinepi.2019.11.012.","journal-title":"J Clin Epidemiol"},{"key":"218_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-017-0450-1","volume":"17","author":"SY Lee","year":"2017","unstructured":"Lee SY, Sagoo H, Farwana R, Whitehurst K, Fowler A, Agha R. Compliance of systematic reviews in ophthalmology with the PRISMA statement. BMC Med Res Methodol. 2017;17:178. https:\/\/doi.org\/10.1186\/s12874-017-0450-1.","journal-title":"BMC Med Res Methodol"},{"key":"218_CR24","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.ogla.2021.01.007","volume":"4","author":"R Qureshi","year":"2021","unstructured":"Qureshi R, Azuara-Blanco A, Michelessi M, Virgili G, Breda JB, Cutolo CA, et al. What do we really know about the effectiveness of glaucoma interventions: an overview of systematic reviews. Ophthalmol Glaucoma. 2021;4:454\u201362. https:\/\/doi.org\/10.1016\/j.ogla.2021.01.007.","journal-title":"Ophthalmol Glaucoma"},{"key":"218_CR25","doi-asserted-by":"publisher","first-page":"1117717.","DOI":"10.1016\/j.jclinepi.2025.111717","volume":"181","author":"M Bondok","year":"2025","unstructured":"Bondok M, Dewidar O, Al-Ani A, Selvakumar R, Ing E, Ramke J, et al. Inequities in glaucoma research: an analysis of Cohrane systematic review and randomised trials. J Epidemiol. 2025;181:1117717. https:\/\/doi.org\/10.1016\/j.jclinepi.2025.111717.","journal-title":"J Epidemiol"},{"key":"218_CR26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ogla.2024.04.002","volume":"7","author":"BE Higgins","year":"2024","unstructured":"Higgins BE, Leonard-Hawkhead B, Azuara-Blanco A. Quality of reporting electronic health record data in glaucoma. Ophthalmol Glaucoma. 2024;7:422\u201330. https:\/\/doi.org\/10.1016\/j.ogla.2024.04.002.","journal-title":"Ophthalmol Glaucoma"},{"key":"218_CR27","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41433-025-03678-5","volume":"39","author":"B Leonard-Hawkhead","year":"2025","unstructured":"Leonard-Hawkhead B, Higgins BE, Wright D, Azuara-Blanco A. AI for Glaucoma: Are we reporting well? A systematic literature review of DECIDE-AI checklist. Eye. 2025;39:1070\u201380. https:\/\/doi.org\/10.1038\/s41433-025-03678-5.","journal-title":"Eye"},{"key":"218_CR28","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1136\/bjophthalmol-2019-315330","volume":"104","author":"P McCann","year":"2020","unstructured":"McCann P, Hogg R, Wright DM, Pose-Bazarra S, Chakravarty U, Peto T, et al. Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA): cohort profile, prevalence, awareness and associations. Br J Ophthalmol. 2020;104:1492\u20139. https:\/\/doi.org\/10.1136\/bjophthalmol-2019-315330.","journal-title":"Br J Ophthalmol"},{"key":"218_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-022-02618-1","volume":"22","author":"IJ McClain","year":"2022","unstructured":"McClain IJ, Rooney DM, Tabin GC. Intraocular pressure screening during high-volume cataract surgery outreach in Ethiopia. BMC Ophthalmol. 2022;22:397. https:\/\/doi.org\/10.1186\/s12886-022-02618-1.","journal-title":"BMC Ophthalmol"},{"key":"218_CR30","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41433-021-01687-8","volume":"36","author":"S Hamid","year":"2022","unstructured":"Hamid S, Desai P, Hysi P, Burr JM, Khawaja AP. Population screening for glaucoma in UK: current recommendations and future directions. Eye. 2022;36:504\u20139. https:\/\/doi.org\/10.1038\/s41433-021-01687-8.","journal-title":"Eye"},{"key":"218_CR31","doi-asserted-by":"publisher","unstructured":"Chou R, Selph S, Blazina I, Bougatsos C, Jungbauer R, Fu R, et al. Screening for glaucoma in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022;327:1998\u20132012. https:\/\/doi.org\/10.1001\/jama.2022.6290.","DOI":"10.1001\/jama.2022.6290"},{"key":"218_CR32","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajo.2017.05.017","volume":"180","author":"D Zhao","year":"2017","unstructured":"Zhao D, Guallar E, Gajwani P, Swenor B, Crew J, Saaddine J, et al. Optimising glaucoma screening in high-risk population: design and 1-year findings of the screening to prevent (SToP) glaucoma study. Am J Ophthalmol. 2017;180:18\u201328. https:\/\/doi.org\/10.1016\/j.ajo.2017.05.017.","journal-title":"Am J Ophthalmol"},{"key":"218_CR33","doi-asserted-by":"publisher","unstructured":"Pizzi LT, Waisbound M, Hark L, Sehmbi H, Lee P, Crews JE, et al. Costs of a community-based glaucoma detection programme: analysis of the Philadelphia glaucoma detection and treatment project. Br J Ophthalmol. 2018;102:225\u201332. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310078.","DOI":"10.1136\/bjophthalmol-2016-310078"},{"key":"218_CR34","doi-asserted-by":"publisher","unstructured":"Xu L, Jonas JB, Cui TT, You QS, Wang YX, Yang H, et al. Beijing eye public health care project. Ophthalmology. 2012;119:1167\u201374. https:\/\/doi.org\/10.1016\/j.ophtha.2011.11.036.","DOI":"10.1016\/j.ophtha.2011.11.036"},{"key":"218_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/ceo.14035","volume":"50","author":"IF Aboobakar","year":"2022","unstructured":"Aboobakar IF, Wiggs JL. The genetics of glaucoma: disease associations, personalised risk assessment and therapeutic opportunities\u2014a review. Clin Exp Ophthalmol. 2022;50:143\u201362. https:\/\/doi.org\/10.1111\/ceo.14035.","journal-title":"Clin Exp Ophthalmol"},{"key":"218_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41588-019-0556-y","volume":"52","author":"JE Craig","year":"2020","unstructured":"Craig JE, Han X, Qassim A, Hassall M, Bailey JNC, Kinzy TG, et al. Multitrait analysis of glaucoma identifies new risk loci and enables polygenic prediction of disease susceptibility and progression. Nat Genet. 2020;52:160\u20136. https:\/\/doi.org\/10.1038\/s41588-019-0556-y.","journal-title":"Nat Genet"},{"key":"218_CR37","doi-asserted-by":"publisher","unstructured":"Michelessi M, Lucenteforte E, Oddone F, Brazzelli M, Parravano M, Franchi S, et al. Optic nerve head and fibre layer imaging for diagnosing glaucoma. Cochrane Database Syst Rev. 2015;CD008803. https:\/\/doi.org\/10.1002\/14651858.CD008803.pub2.","DOI":"10.1002\/14651858.CD008803.pub2"},{"key":"218_CR38","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.survophthal.2017.01.001","volume":"62","author":"M Fallon","year":"2017","unstructured":"Fallon M, Valero O, Pazos M, Anton A. Diagnostic accuracy of imaging devices in glaucoma: a meta-analysis. Surv Ophthalmol. 2017;62:446\u201361. https:\/\/doi.org\/10.1016\/j.survophthal.2017.01.001.","journal-title":"Surv Ophthalmol"},{"key":"218_CR39","doi-asserted-by":"publisher","first-page":"10090.","DOI":"10.1016\/j.preteyeres.2020.100900","volume":"82","author":"JPO Li","year":"2021","unstructured":"Li JPO, Liu H, Ting DSJ, Jeon S, Chan RVP, Kim JE, et al. Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective. Prog Retin Eye Res. 2021;82:10090. https:\/\/doi.org\/10.1016\/j.preteyeres.2020.100900.","journal-title":"Prog Retin Eye Res"},{"key":"218_CR40","doi-asserted-by":"publisher","first-page":"420.","DOI":"10.3390\/biomedicines13020420","volume":"13","author":"XC Ling","year":"2025","unstructured":"Ling XC, Chen HSL, Yeh PH, Cheng YC, Hunag CY, Shen SC, et al. Deep learning in glaucoma detection and progression prediction: a systematic review and meta-analysis. Biomedicines. 2025;13:420. https:\/\/doi.org\/10.3390\/biomedicines13020420.","journal-title":"Biomedicines"},{"key":"218_CR41","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.survophthal.2022.08.005","volume":"68","author":"LJ Coan","year":"2023","unstructured":"Coan LJ, Williams BM, Adithya VK, Upadhyaya S, Alkafri A, Czanner S, et al. Automatic detection of glaucoma via fundus imaging and artificial intelligence: a review. Surv Ophthalmol. 2023;68:17\u201341. https:\/\/doi.org\/10.1016\/j.survophthal.2022.08.005.","journal-title":"Surv Ophthalmol"},{"key":"218_CR42","doi-asserted-by":"publisher","first-page":"4473.","DOI":"10.3390\/ijms26104473","volume":"26","author":"CH Lan","year":"2025","unstructured":"Lan CH, Chiu TH, Yen WT, Lu DW. Artificial intelligence in glaucoma: advances in diagnosis, progression forecasting and surgical outcome prediction. Int J Mol Sci. 2025;26:4473. https:\/\/doi.org\/10.3390\/ijms26104473.","journal-title":"Int J Mol Sci"},{"key":"218_CR43","doi-asserted-by":"publisher","first-page":"122.","DOI":"10.3390\/bioengineering11020122","volume":"11","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Salowe R, Chow C, Li S, Bastani O, O\u2019Brien JM. Advancing glaucoma care: integrating artificial intelligence in diagnosis, management and progression detection. Bioengineering. 2024;11:122. https:\/\/doi.org\/10.3390\/bioengineering11020122.","journal-title":"Bioengineering"},{"key":"218_CR44","doi-asserted-by":"publisher","unstructured":"Rao DP, Shroff S, Savoy FM, Shruthi S, Hsu CK, Negiloni K, et al. Evaluation of an offline, artificial intelligence system for referrable glaucoma screening using a smartphone based fundus camera: a prospective study. Eye. 2024;38:1104\u201311. https:\/\/doi.org\/10.1038\/s41433-023-02826-z.","DOI":"10.1038\/s41433-023-02826-z"},{"key":"218_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01473-w","volume":"8","author":"P Sharma","year":"2025","unstructured":"Sharma P, Takahashi N, Ninomiya T, Sato M, Miya T, Tsuda S, et al. A hybrid multi-modal artificial intelligence approach for glaucoma screening using fundus images. npj Digit Med. 2025;8:130. https:\/\/doi.org\/10.1038\/s41746-025-01473-w.","journal-title":"npj Digit Med"},{"key":"218_CR46","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/IJG.0000000000002359","volume":"33","author":"J Huang","year":"2024","unstructured":"Huang J, Galal G, Mukhin V, Etemadi M, Tanna AP. Prediction and detection of glaucomatous visual field progression using deep learning on macular optical coherence tomography. J Glaucoma. 2024;33:246\u201353. https:\/\/doi.org\/10.1097\/IJG.0000000000002359.","journal-title":"J Glaucoma"},{"key":"218_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ajo.2024.02.007","volume":"262","author":"V Mohammadzadeh","year":"2024","unstructured":"Mohammadzadeh V, Wu S, Besharati S, Davis T, Vepa A, Morales E, et al. Prediction of visual field progression with baseline and longitudinal structural measurements using deep learning. Am J Ophthalmol. 2024;262:141\u201352. https:\/\/doi.org\/10.1016\/j.ajo.2024.02.007.","journal-title":"Am J Ophthalmol"},{"key":"218_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-02321-7","volume":"9","author":"YG Liang","year":"2026","unstructured":"Liang YG, Fan L, Teixeira-Pinto A, Liew G, White AJR. A systematic review of AI for predicting glaucoma progression: challenges and recommendations towards clinical implementation. npj Digit Med. 2026;9:140. https:\/\/doi.org\/10.1038\/s41746-025-02321-7.","journal-title":"npj Digit Med"},{"key":"218_CR49","doi-asserted-by":"publisher","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma (5th Edition). Br J Ophthalmol. 2021;105:1\u2013169. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-egsguidelines.","DOI":"10.1136\/bjophthalmol-2021-egsguidelines"},{"key":"218_CR50","doi-asserted-by":"publisher","unstructured":"Pazos M, Traverso CE, Viswanathan A. European Glaucoma Society Guidelines Task Force. European Glaucoma Society Terminology and Guidelines for Glaucoma (6th Edition). Br J Ophthalmol. 2025;109:1\u2013212. https:\/\/doi.org\/10.1136\/bjophthalmol-2025-egsguidelines.","DOI":"10.1136\/bjophthalmol-2025-egsguidelines"},{"key":"218_CR51","doi-asserted-by":"publisher","first-page":"e110718.","DOI":"10.1136\/bmjopen-2025-110718","volume":"15","author":"EY Matayan","year":"2025","unstructured":"Matayan EY, Burn H, Gordon I, Evans J, Toews I, Ramke J, et al. Indicators for effective glaucoma care coverage in adults: protocol for a scoping review. BMJ Open. 2025;15:e110718. https:\/\/doi.org\/10.1136\/bmjopen-2025-110718.","journal-title":"BMJ Open"},{"key":"218_CR52","doi-asserted-by":"publisher","first-page":"6.","DOI":"10.1186\/s40662-017-0071-0","volume":"4","author":"YB Liang","year":"2017","unstructured":"Liang YB, Zhang Y, Musch DC, Congdon N. Proposing new indicators for glaucoma healthcare service. Eye Vis. 2017;4:6. https:\/\/doi.org\/10.1186\/s40662-017-0071-0.","journal-title":"Eye Vis"},{"key":"218_CR53","doi-asserted-by":"publisher","first-page":"e031442.","DOI":"10.1136\/bmjopen-2019-031442","volume":"10","author":"C Lunny","year":"2020","unstructured":"Lunny C, Ramasubbu C, Gerrish S, Liu T, Salwedel DM, Puil L, et al. Impact and use of reviews and overview of reviews to inform clinical practice guideline recommendations: protocol for a methods study. BMJ Open. 2020;10:e031442. https:\/\/doi.org\/10.1136\/bmjopen-2019-031442.","journal-title":"BMJ Open"},{"key":"218_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD015436.pub2","volume":"12","author":"MP Piyasena","year":"2025","unstructured":"Piyasena MP, Daka Q, Qureshi R, Roberti G, Michelessi M, Liu SH, et al. Prognostic factors associated with progression of open-angle glaucoma in adults. Cochrane Database Sys Rev. 2025;12:CD015436. https:\/\/doi.org\/10.1002\/14651858.CD015436.pub2.","journal-title":"Cochrane Database Sys Rev"},{"key":"218_CR55","doi-asserted-by":"publisher","unstructured":"Mimouni M, Mimouni F, Segev F. Conclusiveness of the Cochrane Eye and Vision Group reviews. BMC Res Notes. 2015;8:242. https:\/\/doi.org\/10.1186\/s13104-015-1221-x.","DOI":"10.1186\/s13104-015-1221-x"}],"container-title":["Ophthalmic and Physiological Optics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44402-026-00218-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44402-026-00218-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:04:38Z","timestamp":1792807478000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44402-026-00218-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1007\/s44402-026-00218-w","relation":{},"ISSN":["0275-5408","1475-1313"],"issn-type":[{"value":"0275-5408","type":"print"},{"value":"1475-1313","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,19]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MPP was an appointed fellow under the Evidence Synthesis Ireland Fellowship programme from 2021 to 2023 at Queen\u2019s University Belfast, funded by Evidence Synthesis Ireland\u2013University of Galway, collaborating with the Cochrane Eyes and Vision Group USA. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics and consent to participate declarations not applicable for this opinion review conducted through analysing publicly available published systematic reviews and meta-analyses.","order":2,"name":"Ethics","label":"Ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent to publish declaration is not applicable.","order":3,"name":"Ethics","label":"consent to bublish declaration","group":{"name":"EthicsHeading","label":"Declarations"}}]}}